Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers November 2012

Emanagers Indices - October 2012's performance of the Opalesque Emanagers Indices

Emerging manager hedge funds and managed futures funds generated losses last month, according to a first estimation based on the data of 298 funds listed in Opalesque Solutions' Emanagers database.

The Emanagers Total Index lost 1.07% in October, reducing its year-to-date performance to +3.33%.  Estimates for September and August were corrected to +0.15% and +0.73%, respectively. Since inception in January 2009, the index posted compounded returns of 62%.

Over the last 12 months, emerging managers gained 2.82% in 7 negative and 5 positive months, compared to 2.87% for the Eurekahedge Hedge Fund Index. Global stocks, tracked by the MSCI World Index, gained approximately 10% in the same period.

Managed futures strategies had their worst month so far this year, while hedge funds experienced only small losses: The Emanagers Hedge Fund Index lost 0.21% (+5.84% YTD), while the Emanagers CTA Index lost 2.14% (-1.98% YTD).

The month of October proved to be a difficult macro environment with declining commodity prices, and changing directional movements of interest rates and equity prices. As a result, most investment strategies came under pressure:

  • Relative value and equity long-bias strategies performed best, with gains of 1.57% and 1.36%. Global macro hedge funds did slightly better than managed futures strategies, but still lost 1.47%.
  • Year-to-date, the ranking is led by event-driven hedge funds with compounded returns of almost 16%.

Over the last 12 months, Opalesque calculated MSCI-correlation coefficients of 87% for Emanagers hedge funds and -38% for Emanagers CTAs,......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for